-
Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
25 Apr 2025 12:00 GMT
… 2 clinical-stage pharmaceutical company dedicated to developing … Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment … a combination study with temozolomide for recurrent small … filters and prior clinical trial outcomes. DRP is …
-
AACR 2025: Colon cancer risk reduction, predicting melanoma spread and new drug therapies among Ohio State findings
25 Apr 2025 09:07 GMT
… Ohio – A new targeted drug treatment for small cell lung cancer, … , doctoral student at the OSUCCC – James and College of Medicine
… led to starting human trials to see if HOSU … understand how two treatments, radiation therapy (RT) and temozolomide (TMZ), …
-
Ohio State Discoveries Highlight Colon Cancer Prevention, Melanoma Spread Prediction, and Innovative Drug Therapies at AACR 2025
25 Apr 2025 05:54 GMT
… therapy (RT) and temozolomide (TMZ) chemotherapy on … future where precision medicine and prevention are … in ongoing clinical trials such as the … treatment paradigmscolon cancer prevention strategiesdihydroorotate dehydrogenase inhibitor therapyinnovative drug …
-
Carthera Reaches Recruitment Milestone in SONOBIRD Pivotal Trial for Recurrent Glioblastoma
22 Apr 2025 12:38 GMT
… the revolutionary SonoCloud® medical device, today announces … temozolomide). The trial also evaluates the effectiveness of the SonoCloud and carboplatin treatment … trials in Europe and the United States. It received FDA … and FDA/EMA Orphan Drug Designation in …
-
Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice
15 Apr 2025 15:06 GMT
… clinical trials in their … medication program improves identification of potential drug interactions, patient understanding of their treatment … [Venclexta; AbbVie], temozolomide [Temodar; Merck]) … Pharmaceuticals Corp; 2024. https://www.accessdata.fda …
-
Neuroendocrine Tumors Clinical Trials And Studies 2025: EMA, PDMA, FDA Approvals, Mechanism Of Action, ROA, NDA, IND, And Companies
09 Apr 2025 02:54 GMT
… Pharmaceutical Technology, TaiRx, Inc., Betta Pharmaceuticals … formulation) and Temozolomide, AlphaMedix, Octreotide … trials, emerging therapies, and leading companies with DelveInsight @ Neuroendocrine Tumors Treatment Drugs … trial evaluation for the treatment …
-
RNA Sequencing Identifies Novel Signaling Pathways and Potential Drug Target Genes Induced by FOSL1 in Glioma Progression and Stemness
05 Apr 2025 08:44 GMT
… reached the mainstream of cancer treatment.
IFIT1, an interferon-induced protein … considered as a potential drug target for glioblastoma treatment.86 Additionally, in … al. ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma …
-
Experimental therapy for brain cancer gives ‘hope’; will be investigated in upcoming trial
04 Apr 2025 10:21 GMT
… glioblastoma.
An international trial will start enrolling … University School of Medicine and principal investigator … rather than just testing drugs and seeing them … adjuvant treatment, including radiation and temozolomide. However, temozolomide will …
-
FDA Gives RPDD to NEO100 for Pediatric-Type Diffuse High-Grade Glioma
03 Apr 2025 17:04 GMT
The FDA has granted rare pediatric …
A phase 1b dose-finding trial (NCT06357377), which has yet … maximum standard pediatric dose of temozolomide (Temodar)—90 mg/ … currently receiving another investigational drug or other anticancer treatments, or have a …
-
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
01 Apr 2025 12:01 GMT
… neurosurgery, radiotherapy, and temozolomide), in patients with … trial confirm and extend previous observations in clinical trials … Professor at Harvard Medical School, Candel Scientific … FDA has also granted Orphan Drug Designation to CAN-2409 for the treatment …